Mutation profile of FLNC gene and its prognostic relevance in patients with hypertrophic cardiomyopathy

Filamin C (FLNC) mutation was reported as a cause of HCM, with a high probability of sudden cardiac death. However, the mutation profile of FLNC, and its relationship with phenotypic expression in HCM, remains to be elucidated.

[1]  V. Álvarez,et al.  Screening of the Filamin C Gene in a Large Cohort of Hypertrophic Cardiomyopathy Patients , 2017, Circulation. Cardiovascular genetics.

[2]  Aleks,et al.  Ventilation disorders diagnosed preoperatively in patients scheduled for isolated on-pump CABG: Do they increase inflammatory response in the early postoperative period? , 2016 .

[3]  L. Calò,et al.  Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. , 2016, Journal of the American College of Cardiology.

[4]  E. Coto,et al.  Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients. , 2016, Genetic testing and molecular biomarkers.

[5]  X. Puente,et al.  Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C , 2016, European Journal of Human Genetics.

[6]  H. Smeets,et al.  Hypertrophic remodelling in cardiac regulatory myosin light chain (MYL2) founder mutation carriers. , 2016, European heart journal.

[7]  J. Schwartzentruber,et al.  Mutations in FLNC are Associated with Familial Restrictive Cardiomyopathy , 2016, Human mutation.

[8]  Lorenzo L. Pesce,et al.  Targeted Analysis of Whole Genome Sequence Data to Diagnose Genetic Cardiomyopathy , 2014, Circulation. Cardiovascular genetics.

[9]  F. Rutten,et al.  [2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy]. , 2014, Kardiologia polska.

[10]  X. Puente,et al.  Mutations in filamin C cause a new form of familial hypertrophic cardiomyopathy , 2014, Nature Communications.

[11]  Ferhaan Ahmad,et al.  Malignant effects of multiple rare variants in sarcomere genes on the prognosis of patients with hypertrophic cardiomyopathy , 2014, European journal of heart failure.

[12]  L. Køber,et al.  Penetrance of Hypertrophic Cardiomyopathy in Children and Adolescents: A 12-Year Follow-up Study of Clinical Screening and Predictive Genetic Testing , 2013, Circulation.

[13]  L. Waddell,et al.  Novel FLNC mutation in a patient with myofibrillar myopathy in combination with late‐onset cerebellar ataxia , 2012, Muscle & nerve.

[14]  Hanns Lochmüller,et al.  Distal myopathy with upper limb predominance caused by filamin C haploinsufficiency , 2011, Neurology.

[15]  Barry J Maron,et al.  2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.

[16]  Barry J Maron,et al.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2011, The Journal of thoracic and cardiovascular surgery.

[17]  Robert H. Brown,et al.  Mutations in the N-terminal actin-binding domain of filamin C cause a distal myopathy. , 2011, American journal of human genetics.

[18]  J. Seidman,et al.  Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. , 2011, Circulation research.

[19]  K. Claeys,et al.  P2.18 A novel missense FLNC mutation causes arrhythmia and late onset myofibrillar myopathy with particular histopathology features , 2010, Neuromuscular Disorders.

[20]  Wei Zhang,et al.  A novel heterozygous deletion–insertion mutation (2695–2712 del/GTTTGT ins) in exon 18 of the filamin C gene causes filaminopathy in a large Chinese family , 2010, Neuromuscular Disorders.

[21]  I. Ferrer,et al.  In-frame deletion in the seventh immunoglobulin-like repeat of filamin C in a family with myofibrillar myopathy , 2009, European Journal of Human Genetics.

[22]  Heidi L Rehm,et al.  Shared genetic causes of cardiac hypertrophy in children and adults. , 2008, The New England journal of medicine.

[23]  C. Heyer,et al.  Clinical and morphological phenotype of the filamin myopathy: a study of 31 German patients. , 2007, Brain : a journal of neurology.

[24]  Hanns Lochmüller,et al.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy. , 2005, American journal of human genetics.

[25]  A. Sonnenberg,et al.  Structural and functional aspects of filamins. , 2001, Biochimica et biophysica acta.

[26]  Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults: Echocardiographic Analysis of 4111 Subjects in the Cardia Study , 1996 .

[27]  J. Gardin,et al.  Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.

[28]  M. Vorgerd,et al.  Filamin C-related myopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[29]  R. Hui,et al.  Prevalence of idiopathic hypertrophic cardiomyopathy in China: a population-based echocardiographic analysis of 8080 adults. , 2004, The American journal of medicine.

[30]  S. Hu.  The Chinese Family , 1988 .